Objectives: Osteoporosis (OP) is a systemic disease caused by imbalance between bone resorption and bone formation, commonly resulting from post-menopausal oestrogen deficiency. Although osteogenic differentiation potential of adipose-derived stem cells (ASCs) has been demonstrated, the effect of OP on osteogenic differentiation of ASCs remains unclear. Here, our work has been designed to compare proliferative capacity and osteogenic differentiation ability of ASCs obtained from osteoporotic mice and normal control mice.
| INTRODUCTION
Osteoporosis (OP) is a prevalent systemic skeletal disease characterized by microarchitecture deterioration of bone tissue and low bone mass, which result in an increased risk of fracture. 1, 2 It is an age-related non-infectious metabolic disease caused by an alteration in the equilibrium between osteoblasts and osteoclasts that commonly results from post-menopausal oestrogen deficiency, and women are four times more likely than men to suffer from OP. [3] [4] [5] [6] In addition, OP is ranked as an important health issue by the World Health Organization.
7
Studies showed that adipogenesis is increased and related to reduced osteogenesis in patients with OP. 8, 9 These changes are associated with reduced trabecular bone volume and number, as well as bone mineral density (BMD), leading to fractures and bone defects. 10, 11 Although efforts have focused on the prevention of fractures and the development of therapeutic approaches for the enhancement of bone mass and bone density, [12] [13] [14] the osteoporotic bone regeneration only attracted less attention.
Adipose-derived stem cells (ASCs) are relatively easier to obtain with a high yield than other types of cells and inter-derived mesenchymal stem cells (MSC); they are also easy to culture, grow fast and are resistant to ageing. 15, 16 In addition, ASCs have shown similar osteogenic differentiation potential to bone marrow-derived stem cells (BMSCs) in vitro and in vivo, 17 and some researchers even believe that
ASCs are superior in some respects to BMSCs.
18
Previous studies from our group showed that ASCs possess good osteogenic potential at ectopic and orthotopic sites. 19 A recent study concluded that ASCs from ovariectomized (OVX) rats have higher osteogenic ability than BMSCs from OVX rats. This indicates that the therapy of OP and osteoporotic bone defects with autologous ASCs may be more efficient. 20 For osteoporotic patients, autologous ASCs transplantation has the advantage of greater safety, stability and portability relative to allogeneic ASCs transplantation. Therefore, autologous ASCs transplantation has a wider scope of applications in cell therapy for OP and osteoporotic bone defects. However, how OP affects the properties of ASCs have not yet been well illustrated.
In the present study, the proliferation ability and osteogenic differentiation potential of ASCs harvested from OVX and control mice were compared to determine the effect of OP on ASCs and to analyse the mechanisms underlying the functional changes of ASCs. Our aim was to establish an experimental foundation for the use of autologousmodified OP-ASCs to repair bone defects in patients with OP.
| MATERIALS AND METHODS

| Establishment of the osteoporotic animal study model
All C57BL/6 mouse procedures were reviewed and approved by the Southwest Medical University Ethical Committee. The animal experiments were conducted in accordance with the guidelines of the Care lel to the spine) was made at 0.5 cm from the spine and 1 cm below the ribs. After the removal of bilateral ovaries, the abdominal muscle tissue and skin were sutured. The same procedure was performed for the animals designed to the Sham group but without ovary removal.
| Micro-tomographic analysis
Six weeks after the operation, six mice from the OVX and Sham groups were randomly selected. The middle right of the femoral shaft specimens from each group mice were scanned by micro-computed tomography, with an Explore Locus SP scanner (GE Healthcare, Buckinghamshire, UK). Microstructural measurements included BMD, bone volume per total volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing.
| Histological examination
The femoral specimens of mice were fixed for 2 weeks with 10% formaldehyde, decalcified in 10% EDTA solution for 2-3 weeks, dehydrated by an alcohol gradient and xylene soak, and placed on baptist wax and embedded. Samples were then sliced and stained with haematoxylin and eosin (H&E) and the changes of trabeculae from ovariectomized mice were observed.
| Isolation and culture of ASCs and OP-ASCs
ASCs and OP-ASCs were obtained from the subcutaneous fat of the in- 
| Cell adhesion and proliferation assay
In this study, the xCELLigence system (Roche Diagnostics GmbH, Basel, Switzerland) was used to monitor cell adhesion and proliferation. For the system, ASCs and OP-ASCs were seeded into 96-well E-plates at 2000 cells/well and the real-time growth was monitored as an impedance value continuously on the RTCA SP xCelligence system for multipotentiality and accessibility of ASCs at 7 days in 5% CO 2 at 37°C. The data were analysed by using the provided RTCA software.
| Osteogenic induction
Third-passage ASCs and OP-ASCs were respectively seeded into six- 
| Alizarin red staining
The mineralized nodules of differentiated ASCs and OP-ASCs were analysed using Alizarin red staining as follows: cells underwent osteogenic induction for 21 days after PBS washing, followed by 4% paraformaldehyde fixation at room temperature for 20 minutes, washing three times in PBS, and incubation in 0.1% Alizarin red dye for 30 minutes at 37°C. Cells were then washed twice in PBS and osteogenic differentiation was observed using an inverted microscope with each hole selected by at least three different vision cameras to save the image.
| Extraction of RNA and real-time RT-PCR
The expression of osteogenic-specific genes including osteopontin (Opn) and runt-related transcription factor 2 (Runx2) was assessed at the transcriptional level by real-time PCR. Total RNA was extracted from fresh cells using the Simply P total RNA extraction kit (BioFlux, Zhejiang, China 
| Western blot assay
| Statistical analysis
All experiments were repeated a minimum of three times independently, and representative data are provided as mean ± SD. P values were calculated using Student's t-test, with spss 17.0 software (SPSS 
| Phenotypic characterization of ASCs and OPASCs
Third-passage ASCs and OP-ASCs were analysed by using a FACS. A representative flow histogram is shown in Figure 3 . Both ASCs and OP-ASCs were negative for the haematopoietic lineage markers CD31
and CD45 and positive for the mesenchymal marker CD29 (Figure 3 ). 
| Cell proliferation curve of ASCs measured from OVX and Sham groups
| OP-ASCs had less mineralized bone nodular structures than ASCs
OP-ASCs and ASCs were cultured in six-well plates. Sequentially, plates were divided into four groups as described above. Induction 
| Runx2 and Opn mRNA transcription was lower in OP-ASCs than in the Sham group
After 3, 5 and 7 days of osteogenic induction, Runx2 and Opn mRNA levels were detected using real-time PCR (Figure 6 ). The mRNA levels of Runx2 in the OVX group were significantly lower than in the Sham group at each time point. Runx2 mRNA levels on day 3 were significantly lower in contrast to days 5 and 7 in both OVX and Sham groups, and transcript levels on day 5 were significantly lower in contrast to day 7. Transcript levels of the gene coding for Opn showed a similar pattern to those of Runx2. However, Opn transcript levels in the OVX group were lower than in the Sham group on day 7, although the difference did not reach statistical significance (Figure 6 ).
| RUNX2 and OPN protein expression was reduced in OP-ASCs compared with the Sham group
The Western blot results showed that the protein expression levels of OPN and RUNX2 in the OVX group were lower than those in the Sham group at each time point. On days 3 and 5, the difference in the expression of OPN between OP-ASCs and ASCs was significant, while the expression of RUNX2 was significant between the two groups at each time point (Figure 7 ).
| DISCUSSION
Osteoporosis is a metabolic disease characterized by bone mass loss and microstructure degeneration, the pathogenesis of which involves an imbalance between osteoblasts and osteoclasts in the process of bone remodelling. Decreased numbers and activity of osteoblasts and increased numbers and enhanced function of osteoclasts lead to bone resorption exceeding bone formation, lead to increased bone fragility and a higher risk of fracture. Based on the pathogenesis of OP, healing OP and repairing the bone defect can be achieved by increasing the number of osteoblasts.
Osteoblasts are derived from BMSCs. Although MSCs can be isolated from various tissues at present, their proportion in various tissues, including the bone marrow, is very low. 26 ASCs are relatively easy to obtain and the output of MSCs is greater than that of other tissues; they grow fast, are easy to cultivate, resistant to ageing and easier to preserve than BMSCs. 15, 16, 27, 28 In addition, the morphology of ASCs under the microscope and their surface markers are similar to those of BMSCs. 29, 30 ASCs were obtained by present isolation approaches inevitably containing complex mixtures of some cell types such as actual stem cells, progenitors, fibroblasts or other cells. These cells other than ASCs may previously also been propagated in error. The identity and purification of ASCs has proved difficult because of lack of specific surface markers. Many studies have reported that a combination of surface markers is useful for identifying stem cells from heterogenic cell populations. As reported, typical ASCs should express specific markers such as CD29, CD44, CD105, CD271 and Sca-1 but not CD34,
CD45
. 19, 30 The data of our experiments are in accord with previous results. Their capacity for osteogenic differentiation in vivo and in vitro F I G U R E 4 Growth curve of ASCs and OP-ASCs as determined by Roche xCelligence for 7 days. After 24 h, the medium of both groups was changed and proliferation was measured continuously for a further 6 days. Each curve represents an average of three replicates is also similar to that of BMSCs. 17 Some studies suggest that ASCs are superior to BMSCs in certain respects, 18 which has made them a research hot topic in recent years. However, additional research is needed before they can be adopted as seed cells, and it is important to compare the proliferation ability and osteogenic differentiation of these cells in vitro and in vivo at early stages. In addition, the effects of OP on the biological characteristics of ASCs remain unclear.
Previous studies showed that the activation and expression of some key genes regulate the differentiation of MSCs to specific phenotypes. 31 The osteogenic differentiation of ASCs is regulated by multiple signalling pathways. 32 The signalling pathways of bone morphogenetic protein, fibroblast growth factor, Notch, Wnt/β-catenin and others are involved in the regulation of the osteogenic differentiation of ASCs. 33 "Cross-talk" can be found between different signalling pathways, which may result in a synergistic effect or antagonistic effect modulating the differentiation of ASCs. 34 In the present study, we compared the proliferative ability and osteogenic differentiation of OP-ASCs from osteoporotic mice with those of normal mouse-derived ASCs to determine the effects of OPs on ASCs. Our studies showed that OP-ASCs had less mineralized nodules than ASCs, and that Runx2
and Opn mRNA transcription were downregulated in OP-ASCs. The growth rate of OP-ASCs was slower than that of ASCs, which is consistent with the conclusion of a previous study analysing BMSCs.
35
Runx2 (also called core-binding factor alpha 1) is a key regulatory transcription factor that promotes bone formation and plays an important role in the regulation of differentiation of osteoblasts and osteoclasts 36, 37 ; it is essential for osteoblastic differentiation, and shows early stage upregulation in the osteoblast differentiation process. 38 In the present study, the results of western blot analysis indicated that RUNX2 protein expression was downregulated in OP-ASCs, which inhibited their osteogenic differentiation process. Meanwhile, RUNX2
expression was lower in OP-ASCs than in control cells, which is in accordance with previous studies on BMSCs. 39 Opn, a highly acidic secreted phosphorylated glycoprotein, is a member of the collagen family that is involved in the osteoblastic phenotype, and it promotes bone remodelling. 40, 41 In mature bone, Opn is activated during new bone formation and plays a crucial role in bone absorption and bone matrix mineralization, maintaining the integrity of bone tissue with respect to the surrounding tissue. 42 Opn is a later marker than Runx2 in the process of osteogenic differentiation. 43 In this study, OPN protein expression levels in the OP-ASCs were lower than those in the ASCs or the combination of composite scaffolds and modified OP-ASCs for the repair of osteoporotic bone defects can overcome the shortcomings of other methods. However, additional research is necessary to determine how to restore or promote the osteogenic differentiation ability of OP-ASCs.
